2014
Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study
Vaz-Luis I, Keating NL, Lin NU, Lii H, Winer EP, Freedman RA. Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study. Journal Of Clinical Oncology 2014, 32: 927-934. PMID: 24516021, PMCID: PMC3948095, DOI: 10.1200/jco.2013.51.1261.Peer-Reviewed Original ResearchConceptsEarly-stage breast cancerCardiac eventsOlder patientsBreast cancerTrastuzumab completionAdjuvant trastuzumabTreatment completionOlder womenHuman epidermal growth factor receptorAdjuvant trastuzumab useAge 76 yearsDays of therapyMost older patientsSignificant cardiac eventsMultivariable logistic regressionEpidermal growth factor receptorGrowth factor receptorMore comorbiditiesTrastuzumab useComorbidity scorePatient ageHospital admissionOptimal treatmentLower oddsMedicare data
2007
Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer
Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E. Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psycho-Oncology 2007, 16: 895-903. PMID: 17245695, DOI: 10.1002/pon.1146.Peer-Reviewed Original ResearchConceptsPsychosocial adjustmentLong-term psychosocial adjustmentWorse adaptationBattery of measuresCancer survivorsFear of recurrenceOlder survivorsYoung survivorsYoung cancer survivorsCancer-related problemsEndometrial cancer survivorsBetter adjustmentDepression ScaleSexual problemsHospital AnxietyLong-term survivorsTreatment completionPhysical functioningOlder breastSurvivorsEndometrial cancerStudy entryAdjustmentMost differencesAnxiety